Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium.
Authors: Howat WJ,  Blows FM,  Provenzano E,  Brook MN,  Morris L,  Gazinska P,  Johnson N,  McDuffus LA,  Miller J,  Sawyer EJ,  Pinder S,  van Deurzen CH,  Jones L,  Sironen R,  Visscher D,  Caldas C,  Daley F,  Coulson P,  Broeks A,  Sanders J,  Wesseling J,  Nevanlinna H,  Fagerholm R,  Blomqvist C,  Heikkilä P,  Ali HR,  Dawson SJ,  Figueroa J,  Lissowska J,  Brinton L,  Mannermaa A,  Kataja V,  Kosma VM,  Cox A,  Brock IW,  Cross SS,  Reed MW,  Couch FJ,  Olson JE,  Devillee P,  Mesker WE,  Seyaneve CM,  Hollestelle A,  Benitez J,  Perez JI,  Menéndez P,  Bolla MK,  Easton DF,  Schmidt MK,  Pharoah PD,  Sherman ME,  García-Closas M
Journal: J Pathol Clin Res
Date: 2015 Jan
Branches: MEB, OD, OEEB
PubMed ID: 27499890
PMC ID: PMC4858117
Abstract: Breast cancer risk factors and clinical outcomes vary by tumour marker expression. However, individual studies often lack the power required to assess these relationships, and large-scale analyses are limited by the need for high throughput, standardized scoring methods. To address these limitations, we assessed whether automated image analysis of immunohistochemically stained tissue microarrays can permit rapid, standardized scoring of tumour markers from multiple studies. Tissue microarray sections prepared in nine studies containing 20 263 cores from 8267 breast cancers stained for two nuclear (oestrogen receptor, progesterone receptor), two membranous (human epidermal growth factor receptor 2 and epidermal growth factor receptor) and one cytoplasmic (cytokeratin 5/6) marker were scanned as digital images. Automated algorithms were used to score markers in tumour cells using the Ariol system. We compared automated scores against visual reads, and their associations with breast cancer survival. Approximately 65-70% of tissue microarray cores were satisfactory for scoring. Among satisfactory cores, agreement between dichotomous automated and visual scores was highest for oestrogen receptor (Kappa = 0.76), followed by human epidermal growth factor receptor 2 (Kappa = 0.69) and progesterone receptor (Kappa = 0.67). Automated quantitative scores for these markers were associated with hazard ratios for breast cancer mortality in a dose-response manner. Considering visual scores of epidermal growth factor receptor or cytokeratin 5/6 as the reference, automated scoring achieved excellent negative predictive value (96-98%), but yielded many false positives (positive predictive value = 30-32%). For all markers, we observed substantial heterogeneity in automated scoring performance across tissue microarrays. Automated analysis is a potentially useful tool for large-scale, quantitative scoring of immunohistochemically stained tissue microarrays available in consortia. However, continued optimization, rigorous marker-specific quality control measures and standardization of tissue microarray designs, staining and scoring protocols is needed to enhance results.